Fate Therapeutics (FATE) Stock Price & Financial Analysis
Fate Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Fate Therapeutics
What is the current stock price for FATE?
As of the latest trading session, FATE stock trades at $1.22. The 52-week range is $0.66–$1.94, with a day range of $1.18–$1.24.
What is the P/E ratio for FATE?
The P/E ratio (Price-to-Earnings) for FATE is shown in the Key Statistics section. This valuation metric helps compare Fate Therapeutics, Inc. to industry peers.
Does FATE pay dividends?
Fate Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for FATE?
Analyst ratings and recommendations for FATE are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of FATE?
Fate Therapeutics's market capitalization is $144.9M, classifying it as a micro-cap company. Fate Therapeutics operates in the Healthcare sector within the Biotechnology industry.